CDH5 and Increased total eosinophil count: Therefore, assessment of IL-4 levels, eosinophilia and soluble VE-cadherin as a possible surrogate marker for endothelial barrier dysfunction might be useful tools to distinguish pirfenidone responders from patients at risk of disease exacerbation.